AGENTS, USES AND METHODS FOR THE TREATMENT OF SYNUCLEINOPATHY
The invention relates to novel monoclonal anti-alpha-synuclein antibodies. The antibodies can be used for treating a synucleinopathy such as Parkinson's disease (including idiopathic and inherited forms of Parkinson's disease), Diffuse Lewy Body Disease (DLBD), Lewy body variant of Alzheim...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | VINK, Tom VESTERAGER, Louise Buur MONTEZINHO, Liliana Christina Pereira FOG, Karina SATIJN, David KALLUNKI, Pekka BERGSTRÔM, Ann-Louise RADEMAKER, Rik MALIK, Ibrahim John VAN DEN BRINK, Edward SOTTY, Florence PARREN, Paul |
description | The invention relates to novel monoclonal anti-alpha-synuclein antibodies. The antibodies can be used for treating a synucleinopathy such as Parkinson's disease (including idiopathic and inherited forms of Parkinson's disease), Diffuse Lewy Body Disease (DLBD), Lewy body variant of Alzheimer's disease (LBV), Combined Alzheimer's and Parkinson disease, pure autonomic failure and multiple system atrophy. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2021147522A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2021147522A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2021147522A13</originalsourceid><addsrcrecordid>eNrjZLB1dHf1CwnWUQgNdg1WcPRzUfB1DfHwdwlWcPMPUgjxcFUICXJ1DPEFKlLwd1MIjvQLdfZx9fTzD3AM8YjkYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxocFGBkaGhibmpkZGjobGxKkCAM0qKsE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>AGENTS, USES AND METHODS FOR THE TREATMENT OF SYNUCLEINOPATHY</title><source>esp@cenet</source><creator>VINK, Tom ; VESTERAGER, Louise Buur ; MONTEZINHO, Liliana Christina Pereira ; FOG, Karina ; SATIJN, David ; KALLUNKI, Pekka ; BERGSTRÔM, Ann-Louise ; RADEMAKER, Rik ; MALIK, Ibrahim John ; VAN DEN BRINK, Edward ; SOTTY, Florence ; PARREN, Paul</creator><creatorcontrib>VINK, Tom ; VESTERAGER, Louise Buur ; MONTEZINHO, Liliana Christina Pereira ; FOG, Karina ; SATIJN, David ; KALLUNKI, Pekka ; BERGSTRÔM, Ann-Louise ; RADEMAKER, Rik ; MALIK, Ibrahim John ; VAN DEN BRINK, Edward ; SOTTY, Florence ; PARREN, Paul</creatorcontrib><description>The invention relates to novel monoclonal anti-alpha-synuclein antibodies. The antibodies can be used for treating a synucleinopathy such as Parkinson's disease (including idiopathic and inherited forms of Parkinson's disease), Diffuse Lewy Body Disease (DLBD), Lewy body variant of Alzheimer's disease (LBV), Combined Alzheimer's and Parkinson disease, pure autonomic failure and multiple system atrophy.</description><language>eng</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PHYSICS ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; TESTING</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210520&DB=EPODOC&CC=US&NR=2021147522A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25566,76549</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210520&DB=EPODOC&CC=US&NR=2021147522A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>VINK, Tom</creatorcontrib><creatorcontrib>VESTERAGER, Louise Buur</creatorcontrib><creatorcontrib>MONTEZINHO, Liliana Christina Pereira</creatorcontrib><creatorcontrib>FOG, Karina</creatorcontrib><creatorcontrib>SATIJN, David</creatorcontrib><creatorcontrib>KALLUNKI, Pekka</creatorcontrib><creatorcontrib>BERGSTRÔM, Ann-Louise</creatorcontrib><creatorcontrib>RADEMAKER, Rik</creatorcontrib><creatorcontrib>MALIK, Ibrahim John</creatorcontrib><creatorcontrib>VAN DEN BRINK, Edward</creatorcontrib><creatorcontrib>SOTTY, Florence</creatorcontrib><creatorcontrib>PARREN, Paul</creatorcontrib><title>AGENTS, USES AND METHODS FOR THE TREATMENT OF SYNUCLEINOPATHY</title><description>The invention relates to novel monoclonal anti-alpha-synuclein antibodies. The antibodies can be used for treating a synucleinopathy such as Parkinson's disease (including idiopathic and inherited forms of Parkinson's disease), Diffuse Lewy Body Disease (DLBD), Lewy body variant of Alzheimer's disease (LBV), Combined Alzheimer's and Parkinson disease, pure autonomic failure and multiple system atrophy.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PHYSICS</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLB1dHf1CwnWUQgNdg1WcPRzUfB1DfHwdwlWcPMPUgjxcFUICXJ1DPEFKlLwd1MIjvQLdfZx9fTzD3AM8YjkYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxocFGBkaGhibmpkZGjobGxKkCAM0qKsE</recordid><startdate>20210520</startdate><enddate>20210520</enddate><creator>VINK, Tom</creator><creator>VESTERAGER, Louise Buur</creator><creator>MONTEZINHO, Liliana Christina Pereira</creator><creator>FOG, Karina</creator><creator>SATIJN, David</creator><creator>KALLUNKI, Pekka</creator><creator>BERGSTRÔM, Ann-Louise</creator><creator>RADEMAKER, Rik</creator><creator>MALIK, Ibrahim John</creator><creator>VAN DEN BRINK, Edward</creator><creator>SOTTY, Florence</creator><creator>PARREN, Paul</creator><scope>EVB</scope></search><sort><creationdate>20210520</creationdate><title>AGENTS, USES AND METHODS FOR THE TREATMENT OF SYNUCLEINOPATHY</title><author>VINK, Tom ; VESTERAGER, Louise Buur ; MONTEZINHO, Liliana Christina Pereira ; FOG, Karina ; SATIJN, David ; KALLUNKI, Pekka ; BERGSTRÔM, Ann-Louise ; RADEMAKER, Rik ; MALIK, Ibrahim John ; VAN DEN BRINK, Edward ; SOTTY, Florence ; PARREN, Paul</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2021147522A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2021</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PHYSICS</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>VINK, Tom</creatorcontrib><creatorcontrib>VESTERAGER, Louise Buur</creatorcontrib><creatorcontrib>MONTEZINHO, Liliana Christina Pereira</creatorcontrib><creatorcontrib>FOG, Karina</creatorcontrib><creatorcontrib>SATIJN, David</creatorcontrib><creatorcontrib>KALLUNKI, Pekka</creatorcontrib><creatorcontrib>BERGSTRÔM, Ann-Louise</creatorcontrib><creatorcontrib>RADEMAKER, Rik</creatorcontrib><creatorcontrib>MALIK, Ibrahim John</creatorcontrib><creatorcontrib>VAN DEN BRINK, Edward</creatorcontrib><creatorcontrib>SOTTY, Florence</creatorcontrib><creatorcontrib>PARREN, Paul</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>VINK, Tom</au><au>VESTERAGER, Louise Buur</au><au>MONTEZINHO, Liliana Christina Pereira</au><au>FOG, Karina</au><au>SATIJN, David</au><au>KALLUNKI, Pekka</au><au>BERGSTRÔM, Ann-Louise</au><au>RADEMAKER, Rik</au><au>MALIK, Ibrahim John</au><au>VAN DEN BRINK, Edward</au><au>SOTTY, Florence</au><au>PARREN, Paul</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>AGENTS, USES AND METHODS FOR THE TREATMENT OF SYNUCLEINOPATHY</title><date>2021-05-20</date><risdate>2021</risdate><abstract>The invention relates to novel monoclonal anti-alpha-synuclein antibodies. The antibodies can be used for treating a synucleinopathy such as Parkinson's disease (including idiopathic and inherited forms of Parkinson's disease), Diffuse Lewy Body Disease (DLBD), Lewy body variant of Alzheimer's disease (LBV), Combined Alzheimer's and Parkinson disease, pure autonomic failure and multiple system atrophy.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_US2021147522A1 |
source | esp@cenet |
subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS TESTING |
title | AGENTS, USES AND METHODS FOR THE TREATMENT OF SYNUCLEINOPATHY |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T12%3A52%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=VINK,%20Tom&rft.date=2021-05-20&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2021147522A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |